CCSD code 0607U: billing endometrial microbiome assessment in UK private practice

Key Takeaways

CCSD code 0607U does not exist as a native CCSD code: 0607U is a US CPT Proprietary Laboratory Analysis (PLA) code for endometrial microbiome assessment via RT-PCR across 31 bacterial targets, not a CCSD procedure code.

UK private clinics billing this test should use the closest applicable CCSD diagnostic or procedural code and contact CCSD if no standard code fits the procedure.

Coverage varies by insurer: Bupa, AXA Health, Aviva, and Allianz Care each apply their own medical policies to reproductive lab tests; some classify microbiome testing as investigational.

Pabau’s claims management software supports CCSD-coded electronic claim submission via Healthcode, reducing manual errors for UK private reproductive medicine practices.

UK billing administrators searching for CCSD code 0607U often hit a wall. The code exists in US coding databases, it appears on US payer policy notifications, and reproductive medicine labs use it when submitting claims under American insurance systems. But search the CCSD Schedule of Procedures and you will not find it. That is not a database error.

This guide explains what 0607U actually is, why UK clinic staff encounter it, and how to handle endometrial microbiome assessment billing correctly under the CCSD system used by Bupa, AXA Health, Aviva, Allianz Care, and other major UK private health insurers.

CCSD code 0607U: what it is and where the confusion starts

The short answer: CCSD code 0607U is not a CCSD code at all. It is a CPT Proprietary Laboratory Analysis (PLA) code issued by the American Medical Association (AMA) under the US Current Procedural Terminology system. All codes in the 0001U-0999U range are AMA PLA codes by definition, assigned to specific proprietary laboratory tests offered by named commercial labs.

CCSD codes, by contrast, are the UK private healthcare sector’s standard for procedure and diagnostic billing. Maintained by the Clinical Coding and Schedule Development group and administered by Grant Thornton UK LLP, CCSD codes follow a distinct numeric format (typically 5 digits prefixed by chapter, such as W8520 for skin procedures). The two systems are entirely separate and there is no direct code-to-code equivalence between CPT PLA codes and CCSD codes.

Confusion arises for two reasons. First, UK fertility and reproductive medicine labs sometimes process samples using test methodologies originally developed for and coded under US laboratory billing conventions. Second, some electronic billing platforms display US CPT codes alongside CCSD codes in search results, creating the impression that 0607U is a valid billing code in both markets. It is not valid under the CCSD system.

The CPT 0607U descriptor in full

According to the AMA’s CPT code set, PLA code 0607U describes an endometrial microbiome assessment via real-time polymerase chain reaction (RT-PCR) measuring 31 bacterial targets. The companion code 0608U covers the same test at 10 bacterial targets. Both fall under the reproductive medicine category of PLA codes and are used in the US context for endometrial receptivity and IVF preparatory investigations. The South Dakota Medicaid APC schedule classifies 0607U as status A (separately payable), APC E1.

For UK providers, this clinical context matters even if the code itself does not apply. The test measures the composition of the uterine microbiome to assess its suitability for embryo transfer, typically during IVF treatment cycles. Understanding what the test does helps UK billing staff identify the right CCSD code for it.

CPT code 0607U: endometrial microbiome assessment explained

The endometrial microbiome assessment covered by CPT 0607U is a relatively new laboratory investigation. It analyses the bacterial composition of the endometrial lining using RT-PCR, identifying whether a patient’s uterine environment is dominated by Lactobacillus species (considered optimal for implantation) or disrupted by a broader range of pathogenic bacteria.

Clinically, this test is used in the fertility clinic setting to guide decisions about embryo transfer timing and antibiotic pre-treatment. Results typically categorise patients as having a Lactobacillus-dominant (LD) or non-Lactobacillus-dominant (NLD) endometrial profile, with NLD profiles associated with lower implantation rates in some published studies.

Coverage status in the US

US payer coverage for 0607U is evolving. Blue Cross NC issued a laboratory procedures medical policy notification dated 25 February 2026 listing 0607U among a broad group of proprietary lab tests under active coverage review. This signals that US payers consider endometrial microbiome testing to be an emerging rather than established technology, and coverage decisions continue to vary by plan and state. UK clinics should not extrapolate US coverage decisions to UK insurer policies, but the US payer landscape does reflect a broader pattern: reproductive microbiome testing remains subject to medical necessity review in most markets.

CCSD code 0607U: how UK private clinics should approach billing

Since 0607U has no direct CCSD equivalent, UK private clinics offering endometrial microbiome testing have two practical options. The right path depends on whether the lab is an in-house facility or an external laboratory to which specimens are referred.

The CCSD official website hosts the Schedule of Procedures behind a member login. If your practice does not yet have access, registration is available directly on the site. The schedule is comprehensive: as of the February 2026 edition, it contains 2,859 procedure codes across 20 chapters. The CCSD Technical Guide (October 2025) explains how codes are structured and how to apply coding principles when no exact match exists for a novel test.

Searching the CCSD schedule for reproductive medicine codes

CCSD codes for gynaecological and reproductive medicine procedures sit primarily in Chapter 5 (Pathology and Laboratory) for diagnostic tests and in the relevant surgical chapters for procedural interventions. When searching for an endometrial test code, use terms such as “endometrial,” “uterine biopsy,” or “microbiological analysis” rather than the test brand name or the CPT descriptor. The CCSD system is coded by anatomical site and procedure type, not by proprietary test name.

For OB/GYN practices already billing reproductive medicine procedures, the same search approach applies for any new test that enters clinical practice before a dedicated CCSD code is created. Document your code selection rationale and keep a record of any CCSD correspondence confirming the appropriate code.

Which UK insurers cover endometrial microbiome testing?

Coverage for endometrial microbiome assessment varies significantly across UK private health insurers. Most policies distinguish between fertility treatment (usually excluded from standard PMI policies) and diagnostic investigations for a pre-existing gynaecological condition (sometimes covered). The distinction matters because microbiome testing may be ordered either as part of an IVF workup or as a standalone diagnostic for recurrent implantation failure.

The Allianz Care UK fee schedule uses CCSD codes as its standard throughout and provides fee rates for procedures across all major chapters. Checking the fee schedule against the CCSD code you intend to use for endometrial testing will confirm whether Allianz Care has a published rate for it. Bupa’s procedure code search is available at codes.bupa.co.uk and allows providers to verify whether a specific code is recognised and at what reimbursement level.

For practices dealing with Bupa procedure code fee schedules regularly, always check the current schedule rather than relying on rates from previous years. Bupa updates its fee schedule periodically and may reclassify or revise payment rates for diagnostic laboratory tests.

Pre-authorisation requirements

Most UK private insurers require pre-authorisation for reproductive medicine investigations, including novel laboratory tests. Submitting a claim for an endometrial microbiome test without prior authorisation is one of the most common reasons for denial in this clinical area. Before the test is performed, confirm with the insurer whether it falls within the patient’s policy coverage and obtain a written authorisation reference.

Some insurers classify endometrial microbiome testing as investigational, meaning coverage may be refused even with pre-authorisation unless the clinical indication meets specific criteria. For patients with recurrent implantation failure, clinicians should document the medical necessity clearly in the referral letter and include published evidence supporting the test’s diagnostic value in the pre-authorisation request.

Streamline your CCSD billing with Pabau

Pabau's claims management tools support electronic CCSD claim submission via Healthcode, reducing errors and speeding up reimbursement for UK private reproductive medicine practices.

Book a demo

Documentation and compliance requirements for UK labs

Billing an endometrial microbiome test correctly under CCSD is only part of the compliance picture. UK private labs performing RT-PCR-based microbiome analysis must also meet regulatory and data governance requirements specific to the UK.

UKAS accreditation

Labs performing endometrial microbiome assessments should hold UKAS (UK Accreditation Service) accreditation under ISO 15189 for medical laboratories. Most UK private insurers require lab accreditation as a condition of recognising test results for reimbursement. Billing a test performed by a non-accredited lab risks claim denial even if the CCSD code itself is correct.

UK GDPR and patient data

Endometrial microbiome data is genetic and health data under the UK General Data Protection Regulation (UK GDPR), classified as a special category. Clinics must obtain explicit informed consent before processing this data, document the legal basis for processing, and retain data only for as long as clinically necessary. The ICO (Information Commissioner’s Office) is the relevant supervisory authority. Practices handling microbiome test data as part of their billing and clinical workflows should review their UK GDPR compliance checklist to confirm data handling processes are adequate.

MHRA considerations

The MHRA (Medicines and Healthcare products Regulatory Agency) regulates in vitro diagnostic devices (IVDs) in the UK. An RT-PCR kit used for endometrial microbiome analysis may be subject to IVD regulations depending on whether it is a CE-marked or UKCA-marked commercial kit or an in-house developed test (IDT). Labs should confirm regulatory status with the manufacturer and document this in their quality management records. This has no direct impact on CCSD billing but is relevant to the lab’s compliance obligations and may affect insurer acceptance of test results.

How to avoid common billing errors for endometrial microbiome tests

Several billing errors appear repeatedly when practices first begin submitting claims for this type of test. Most are avoidable with the right preparation.

• Using CPT 0607U on a CCSD claim form. This will always result in rejection. UK private health insurers do not recognise US PLA codes. Replace with the applicable CCSD code or request guidance from CCSD before submitting.
• Failing to obtain pre-authorisation. Reproductive medicine investigations almost always require prior approval. Submitting first and seeking authorisation after a denial adds weeks of delay and administrative cost.
• Incorrect code chapter. Applying a procedure code from a surgical chapter to a purely diagnostic laboratory test will trigger a coding mismatch. Confirm whether the test is being billed as a procedure or a diagnostic service and use the corresponding CCSD chapter.
• Missing insurer-specific coding requirements. Some insurers add supplementary requirements to CCSD codes, such as mandatory diagnostic codes submitted alongside the procedure code. Check the insurer’s provider portal or coding guidance for any such requirements before first submission.
• Stale fee schedule data. Using a fee schedule from a prior year when submitting to Bupa, AXA Health, or Aviva may result in underpayment or rejection if a code’s status has changed. Always use the current published schedule.

Practices running integrated claims management software can reduce several of these errors through automated code validation and submission workflows. For sexual health and reproductive medicine clinics handling high volumes of insurer-billed diagnostic tests, building these checks into the billing workflow rather than relying on manual review significantly lowers the denial rate.

Electronic submission via Healthcode, the UK private healthcare claims clearinghouse, provides real-time validation against insurer rules at the point of submission. Practices not yet submitting electronically through Healthcode should consider this as a priority step for reducing claims processing time. Pabau’s lab management tools support the documentation side of this workflow, linking test orders, results, and billing codes within a single patient record.

Conclusion

CPT code 0607U is a US PLA code for endometrial microbiome assessment and has no direct equivalent in the CCSD system. UK private clinics encountering this code should use the closest applicable CCSD diagnostic or procedural code, obtain insurer pre-authorisation before the test is performed, and contact CCSD directly if no suitable code exists.

Getting this right requires clean documentation, current fee schedule data, and electronic submission that validates codes against insurer rules before claims leave the practice. Pabau’s claims management software supports CCSD-coded electronic submission via Healthcode, reducing the manual work involved in managing these edge cases for UK fertility and reproductive medicine practices. To see how Pabau handles billing workflows for private reproductive medicine, book a demo.

Continue your research

Need a full guide to CCSD procedure codes for UK private billing? Bupa CCSD codes: complete guide for UK clinics covers code structure, insurer submission, and avoiding claim denials across the full CCSD schedule.

Billing for IVF and reproductive medicine procedures? IVF CPT codes explains the US CPT codes used for in vitro fertilisation procedures, useful context for UK labs working across both billing systems.

Managing fertility patient records and billing in one place? Fertility clinic software shows how Pabau supports scheduling, documentation, and claims for UK fertility practices.

Frequently Asked Questions